Curaleaf Holdings, Inc. ( CURLF) - Key Metrics
CURLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.28 | $0.05 | $0.11 | $0.05 |
| 2026Q1 | $1.24 | $0.27 | $0.08 | $0.02 |
| 2025Q4 | $1.31 | -$0.24 | $0.17 | $0.11 |
| 2025Q3 | $1.26 | -$0.22 | $0.19 | $0.13 |
| 2025Q2 | $1.27 | -$0.21 | $0.02 | -$0.04 |
CURLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0.16% | 54.05 |
| 2026Q1 | 0% | 5.94 |
| 2025Q4 | 0% | -8.01 |
| 2025Q3 | 0% | -9.46 |
| 2025Q2 | 0% | -2.95 |
CURLF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.46% | 0.00% |
| 2026Q1 | 0.24% | 0% |
| 2025Q4 | 1.40% | 0% |
| 2025Q3 | 1.50% | 0% |
| 2025Q2 | -1.42% | 0% |
CURLF
Price: $9.70
52 week price:
Earnings Per Share: -0.36 USD
P/E Ratio: -6.33
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 2.6 billion